supplementation in COVID-19

Phase 3

Recruiting

• Conditions: COVID-19.; COVID-19; U07.1

• Registration Number: IRCT20200319046819N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age between 20 and 60 years
Both males and females
COVID-19 clinical or definitive diagnosis
Satisfaction with the study
patient do not participate in other trial designs
BMI: 18.5-30 -
Lack of renal and hepatic abnormalities

Exclusion Criteria

Patients with specific and rare viral diseases such as HIV etc.
Patients have been undergoing chemotherapy for the past month
Any other patients that the specialist knows to be unique.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
WBC, CRP, IL6,TNF-a, IFN-G ? ESR. Timepoint: Before and after intervention. Method of measurement: Laboratory blood test.;Intensity of pulmonary involvement. Timepoint: Before and after intervention. Method of measurement: CT scan.;Mortality. Timepoint: Before and after intervention. Method of measurement: Observation.

Secondary Outcome Measures

Name	Time	Method
Body Mass Index. Timepoint: Before and after intervention. Method of measurement: Measuring weight and height and using the formula.;Duration of hospitalization. Timepoint: Before and after intervention. Method of measurement: Observation.;Saturation percentage of blood oxygen. Timepoint: Before and after intervention. Method of measurement: Oxymeter.